Childhood Spinal Cord Neoplasm
5 clinical trials · Condition
◉ Watch Childhood Spinal Cord Neoplasm
| Record | Firm | Date |
|---|---|---|
| Vorinostat, Temozolomide, or Bevacizumab in Combination With Radiation Therapy Followed by Bevacizumab and Temozolomide in Young Patients With Newly Diagnosed High-Grade Glioma (NCT01236560) | National Cancer Institute (NCI) | 2011-01-26 |
| Bevacizumab and Irinotecan in Treating Young Patients With Recurrent, Progressive, or Refractory Glioma, Medulloblastoma, Ependymoma, or Low Grade Glioma (NCT00381797) | National Cancer Institute (NCI) | 2006-08-01 |
| Ispinesib in Treating Young Patients With Relapsed or Refractory Solid Tumors or Lymphoma (NCT00363272) | National Cancer Institute (NCI) | 2006-06-01 |
| AZD2171 in Treating Young Patients With Recurrent, Progressive, or Refractory Primary CNS Tumors (NCT00326664) | National Cancer Institute (NCI) | 2006-03-01 |
| FR901228 in Treating Children With Refractory or Recurrent Solid Tumors or Leukemia (NCT00053963) | National Cancer Institute (NCI) | 2002-09-01 |
Track Childhood Spinal Cord Neoplasm automatically
Every clearance here is in the API, with alerts when new ones post.